Two Biosimilars Approved in Europe for Autoimmune Disorders Two Biosimilars Approved in Europe for Autoimmune Disorders
The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn ' s disease.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 26, 2024 Category: Allergy & Immunology Tags: Pharmacist News Alert Source Type: news
Can Neosporin Protect You From Getting COVID-19?
For years, researchers have been working on vaccines that aim to prevent viral infections by strengthening immune defenses at viruses’ doorway to the body: the nose.
A small study recently published in PNAS presents a similar, if lower-tech, idea. Coating the inside of the nose with the over-the-counter antibiotic ointment Neosporin seems to trigger an immune response that may help the body repel respiratory viruses like those that cause COVID-19 and the flu, the study suggests.
[time-brightcove not-tgx=”true”]
The research raises the idea that Neosporin could serve as an “extra layer” ...
Source: TIME: Health - April 26, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Injectable antibody drug protects children from malaria in Mali trial
A single dose of an experimental antibody drug protects children from malaria for up to 6 months, according to a clinical study published today in
The New England Journal of Medicine
.
The therapy, an injectable monoclonal antibody called L9LS that has
already shown success in adults
, reduced infections and clinical disease in 6- to 10-year-olds in Mali. Although the drug is still undergoing clinical testing, the results suggest monoclonal antibodies could be an important addition to the arsenal against this deadly disease, researchers say.
Malaria caused an estimated 608,000 deaths in 2022...
Source: ScienceNOW - April 26, 2024 Category: Science Source Type: news
British Societies Develop First'Living' Beh çet Guidelines British Societies Develop First'Living' Beh çet Guidelines
The British Society for Rheumatology and the British Association of Dermatologists developed guidelines for the management of people living with Beh çet ' s disease.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 26, 2024 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
More Cases of Asthma, COPD, Hypertension After Military Burn Pit Exposure
(MedPage Today) -- Prolonged deployment to military bases with open burn pits was associated with increased risks for certain respiratory and cardiovascular diseases, according to a retrospective cohort study using Veterans Health Administration... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - April 26, 2024 Category: Allergy & Immunology Source Type: news
New Centre for Applied Excellence in Skin and Allergy Research at Bristol
A new Centre for Applied Excellence in Skin and Allergy Research (CAESAR) is to be set up at Bristol. Led by Matthew Ridd, GP and Professor of Primary Health Care, the Centre seeks to improve the diagnosis and treatment of common skin and allergy problems in primary care. (Source: University of Bristol news)
Source: University of Bristol news - April 25, 2024 Category: Universities & Medical Training Tags: Health, Grants and Awards, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School Source Type: news
Vaccine Safety and DMT for Highly Active MS: New Data Vaccine Safety and DMT for Highly Active MS: New Data
Many clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 24, 2024 Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news
Allergies can make you miserable. Here's how to track pollen levels near you
Allergy season is here, but it doesn't have to make you miserable (Source: ABC News: Health)
Source: ABC News: Health - April 24, 2024 Category: Consumer Health News Tags: Health Source Type: news
Are Direct-to-Consumer Microbiome Tests Clinically Useful? Are Direct-to-Consumer Microbiome Tests Clinically Useful?
Some companies claim they can identify and treat gastrointestinal problems with proprietary technology and products — experts disagree.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 24, 2024 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Investor Update - April 24, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Media News - April 24, 2024 Category: Pharmaceuticals Source Type: news
Hepatitis Kills 3500 People Each Day, Says WHO Hepatitis Kills 3500 People Each Day, Says WHO
Although annual incidence decreased from 2.5 million in 2019 to 2.2 million in 2022, the WHO considers it to be high.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 24, 2024 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Beyond weight loss: Five Yale experts on the benefits of exercise
Five Yale physicians in areas ranging from infectious diseases to allergy and immunology discuss why exercise is key to optimal health. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 23, 2024 Category: Universities & Medical Training Source Type: news
Conscience Laws: Inform Patients Early of All Options Conscience Laws: Inform Patients Early of All Options
Ethicist Art Caplan discusses the rise of state conscience laws and doctors ' obligation to inform patients of all options for receiving care.Medscape Business of Medicine (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 23, 2024 Category: Allergy & Immunology Tags: Family Medicine/Primary Care Commentary Source Type: news
When Red-Hot Isn't Enough: CDC's Heat Risk Tool Sets Magenta as Most Dangerous Level
(MedPage Today) -- Forget about red hot. A new color-coded heat warning system relies on magenta to alert Americans to the most dangerous conditions they may see this summer.
The National Weather Service and the CDC on Monday -- Earth Day ... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - April 23, 2024 Category: Allergy & Immunology Source Type: news
